Beyond Air, Inc. (XAIR)
XAIR Stock Price Chart
Explore Beyond Air, Inc. interactive price chart. Choose custom timeframes to analyze XAIR price movements and trends.
XAIR Company Profile
Discover essential business fundamentals and corporate details for Beyond Air, Inc. (XAIR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
12 Jun 2018
Employees
107.00
Website
https://www.beyondair.netCEO
Amir Avniel
Description
Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing LungFit PRO, a product intended for various viral lung ailments like community-acquired viral pneumonia (including COVID-19) and bronchiolitis in hospital settings. It is also creating LungFit GO, which aims to treat nontuberculous mycobacteria infections. The organization adopted its current name, Beyond Air, Inc., in June 2019, having previously been known as AIT Therapeutics, Inc. Its headquarters are situated in Garden City, New York.
XAIR Financial Timeline
Browse a chronological timeline of Beyond Air, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$10.10, while revenue estimate is $1.86m.
Stock split effective on 13 Jul 2026
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 26 Jun 2026
EPS came in at -$15.40 falling short of the estimated -$11.33 by -35.88%, while revenue for the quarter reached $1.91m , missing expectations by -16.95%.
Earnings released on 13 Feb 2026
EPS came in at -$0.85 surpassing the estimated -$15.01 by +94.34%, while revenue for the quarter reached $2.19m , beating expectations by +1.89%.
Earnings released on 10 Nov 2025
EPS came in at -$1.25 surpassing the estimated -$15.47 by +91.92%, while revenue for the quarter reached $1.82m , missing expectations by -28.32%.
Earnings released on 12 Aug 2025
EPS came in at -$30.60 falling short of the estimated -$30.00 by -2.00%, while revenue for the quarter reached $1.76m , missing expectations by -32.03%.
Stock split effective on 14 Jul 2025
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 Jun 2025
EPS came in at -$1.80 surpassing the estimated -$2.80 by +35.71%, while revenue for the quarter reached $1.15m , missing expectations by -16.42%.
Earnings released on 10 Feb 2025
EPS came in at -$3.00 surpassing the estimated -$3.60 by +16.67%, while revenue for the quarter reached $1.07m , beating expectations by +14.55%.
Earnings released on 11 Nov 2024
EPS came in at -$5.60 surpassing the estimated -$6.00 by +6.67%, while revenue for the quarter reached $798.00k , missing expectations by -22.55%.
Earnings released on 8 Aug 2024
EPS came in at -$1.08 falling short of the estimated -$0.07 by -1.49k%, while revenue for the quarter reached $683.00k , meeting expectations.
Earnings released on 24 Jun 2024
EPS came in at -$7.20 surpassing the estimated -$9.60 by +25.00%, while revenue for the quarter reached $469.00k , missing expectations by -36.89%.
Earnings released on 12 Feb 2024
EPS came in at -$10.00 surpassing the estimated -$10.60 by +5.66%, while revenue for the quarter reached $391.00k , missing expectations by -12.96%.
Earnings released on 13 Nov 2023
EPS came in at -$10.20 falling short of the estimated -$9.40 by -8.51%, while revenue for the quarter reached $240.00k , missing expectations by -49.58%.
Earnings released on 10 Aug 2023
EPS came in at -$9.00 surpassing the estimated -$9.20 by +2.17%, while revenue for the quarter reached $59.00k , missing expectations by -82.20%.
Earnings released on 26 Jun 2023
EPS came in at -$13.40 falling short of the estimated -$9.20 by -45.65%.
Earnings released on 9 Feb 2023
EPS came in at -$8.60 falling short of the estimated -$8.40 by -2.38%.
Earnings released on 8 Nov 2022
EPS came in at -$8.00 falling short of the estimated -$7.20 by -11.11%.
Earnings released on 11 Aug 2022
EPS came in at -$7.40 surpassing the estimated -$9.35 by +20.86%.
Earnings released on 28 Jun 2022
EPS came in at -$5.20 falling short of the estimated -$4.80 by -8.33%.
Earnings released on 10 Feb 2022
EPS came in at -$5.80 falling short of the estimated -$5.00 by -16.00%.
Earnings released on 11 Nov 2021
EPS came in at -$7.20 falling short of the estimated -$5.00 by -44.00%.
Earnings released on 10 Aug 2021
EPS came in at -$6.20 falling short of the estimated -$3.80 by -63.16%.
XAIR Stock Performance
Access detailed XAIR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
